美国FDA药品溶出方法数据库

药品通用名称	剂型	USP溶出装置	速度	溶出介质	介质体积	建议取样时间（分钟）	更新日期
Hydrochlorothiazide/Quinapril HCl	Tablet			Develop a dissolution method			2023/09/15
Hydrochlorothiazide/Spironolactone	Tablet			Refer to USP			2009/08/27
Hydrochlorothiazide/Telmisartan	Tablet			Refer to USP			2016/06/30
Hydrochlorothiazide/Triamterene	Tablet			Refer to USP			2013/07/31
Hydrochlorothiazide/Valsartan	Tablet			Refer to USP			2016/07/28
Hydrochlorothizide/Triamterene	Capsule			Refer to USP			2008/10/06
Hydrocodone Bitartrate	Capsule (Extended Release)	I (Basket)	100	0.05 M Phosphate Buffer, pH 6.8	500	1, 2, 4, 6, 8, 10 and 12 hours	2015/05/28
Hydrocodone Bitartrate	Tablet (Extended Release)	I (Basket-10 mesh)	100	Simulated gastric fluid (SGF) without enzyme (pH 1.2)	900	1, 2, 4, 8, 12, 16, 20 and 24 hours	2016/04/14
Hydrocodone Bitartrate/Ibuprofen	Tablet	II (Paddle)	50	Phosphate Buffer, pH 7.2	900	5, 10, 15 and 30	2004/02/04
Hydrocortisone	Tablet			Develop a dissolution method			2024/01/03
Hydrocortisone	Granule			Refer to FDA's Dissolution Guidance, 2018			2026/05/22
Hydromorphone HCl	Tablet (Extended Release)			Develop a dissolution method			2023/09/15
Hydromorphone HCl	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Hydroxychloroquine Sulfate	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/04/16
Hydroxyurea	Capsule			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Hydroxyurea	Tablet			Refer to FDA's Dissolution Guidance, 2018			2022/07/07
Hydroxyzine HCl	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Hydroxyzine Pamoate	Capsule			Refer to USP			2009/04/02
Hydroxyzine Pamoate	Suspension			Develop a dissolution method			2009/04/02
Ibandronate Sodium	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02